Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with juvenile dermatomyositis correlating with disease activity Juvenile dermatomyositis ( JDM) is a rare autoimmune disorder, affecting mainly muscles and skin. The mainstay of treatment is high dose corticosteroids, combined with other immunosuppres-sive drugs.1 In about 30 % of patients, the disease cannot be controlled despite multiple treatment interventions. Autologous stem cell transplantation (aSCT) has been reported as a last resort treatment in refractory patients with autoimmun
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease, which usually presents wit...
Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical ...
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already o...
Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of...
Juvenile dermatomyositis is an autoimmune disease seen in children, which causes typical skin change...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Abstract Objective To follow up the refractory juvenile dermatomyositis (JDM) with autologous hemato...
Juvenile dermatomyositis (JDM) is a chronic multisystem inflammatory disease that primarily involves...
Introduction Juvenile dermatomyositis is a rare autoimmune dis-ease characterised by profound muscle...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease, which usually presents wit...
Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical ...
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already o...
Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of...
Juvenile dermatomyositis is an autoimmune disease seen in children, which causes typical skin change...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Juvenile dermatomyositis is an autoimmune diseaseseen in children, which causes typical skin changes...
Abstract Objective To follow up the refractory juvenile dermatomyositis (JDM) with autologous hemato...
Juvenile dermatomyositis (JDM) is a chronic multisystem inflammatory disease that primarily involves...
Introduction Juvenile dermatomyositis is a rare autoimmune dis-ease characterised by profound muscle...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
International audienceAbstract Objectives To assess the efficacy and tolerance of the conventional f...
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease, which usually presents wit...
Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical ...
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already o...